AUSTIN, Texas, Sept. 12, 2024 /PRNewswire/ — NeuFit is revolutionizing neurological rehabilitation with its innovative approach that integrates advanced diagnostics and therapeutic technologies. At the center of NeuFit’s success is the NEUBIE (Neuro-Bio-Electric Stimulator), a cutting-edge device that utilizes direct current (DC) electrical stimulation to promote accelerated recovery, enhance performance, and improve overall well-being. This press release highlights NeuFit’s unique approach and its multi-site clinical trial collaboration with Hands-On Diagnostics (HODS) to address neuropathy.

Researchers at the University of Pittsburgh are pioneering a new approach to blood pressure monitoring—using the devices we carry with us every day.

“We are adding a new layer of control between the world of computers and what your eyes see,” says Barmak Heshmat, co-founder of Brelyon and a former MIT postdoc.

iRhythm Technologies (Nasdaq: IRTC)+ announced that it received approval in Japan for its Zio long-term continuous monitoring (LTCM) system.

Researchers at the Georgia Institute of Technology have developed a deep learning (DL) model that they paired with a wearable patch equipped with a highly sensitive sensor that can automatically detect wheezing sounds